By Nidal al-Mughrabi and Charlotte Greenfield GAZA/CAIRO/JERUSALEM (Reuters) -In a makeshift tent on a Gazan beach, ...

The prefilled syringe presentation offers a convenient administration option to healthcare professionals.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...

GSK received Food and Drug Administration approval for a prefilled syringe presentation of Singrix, a prevention vaccine for shingles. The syringe removes the need to reconstitute separate vials ...

Prefilled syringe presentation offers a convenient administration option to healthcare professionals An estimated one million people develop shingles in the US each year 1 PHILADELPHIA-- (BUSINESS ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to increase adult vaccination against shingles (herpes zoster).

This article examines the evolving definitions of ultra-processed food (UPF) and their impact on food industry regulation, product innovation, and health tech. From Nova to new pharma- and app-driven ...